Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 1883Carcinoma, Non-Small-Cell Lung 1345Prostatic Neoplasms 980Colorectal Neoplasms 848Multiple Myeloma 740Leukemia, Myeloid, Acute 725Neoplasms 689Lung Neoplasms 678Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 566Stomach Neoplasms 522Leukemia 511Recurrence 490Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 450Lymphoma, Non-Hodgkin 442Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 422Myelodysplastic Syndromes 416Squamous Cell Carcinoma of Head and Neck 415Head and Neck Neoplasms 402Brain Neoplasms 402Rectal Neoplasms 395Glioblastoma 374Carcinoma, Renal Cell 349Hodgkin Disease 338Lymphoma, Follicular 336

Interventions

dolutegravir 1acalabrutinib 1Tenofovir 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Neuritis × Clear all
NCT07555431 2026-05-04

DOT-H

Fundação Bahiana de Infectologia

Phase 2 Not yet recruiting
146 enrolled
LymphoidOther hematologic neoplasm

Neuritis, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, Paraparesis, Tropical Spastic

NCT05065554 2025-12-05

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
12 enrolled
Lymphoid

Waldenstrom Macroglobulinemia, Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡